184 related articles for article (PubMed ID: 38163879)
21. [Autoimmune encephalitis, clinical, radiological and immunological data].
Aupy J; Collongues N; Blanc F; Tranchant C; Hirsch E; De Seze J
Rev Neurol (Paris); 2013 Feb; 169(2):142-53. PubMed ID: 23099105
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
Valencia Sanchez C; Theel E; Binnicker M; Toledano M; McKeon A
Neurology; 2021 Dec; 97(23):e2262-e2268. PubMed ID: 34635560
[TBL] [Abstract][Full Text] [Related]
23. General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.
Masciocchi S; Businaro P; Scaranzin S; Morandi C; Franciotta D; Gastaldi M
Crit Rev Clin Lab Sci; 2024 Jan; 61(1):45-69. PubMed ID: 37777038
[TBL] [Abstract][Full Text] [Related]
24. Prognosticating autoimmune encephalitis: A systematic review.
Broadley J; Seneviratne U; Beech P; Buzzard K; Butzkueven H; O'Brien T; Monif M
J Autoimmun; 2019 Jan; 96():24-34. PubMed ID: 30595145
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis.
Yamakawa M; Mukaino A; Kimura A; Nagasako Y; Kitazaki Y; Maeda Y; Higuchi O; Takamatsu K; Watari M; Yoshikura N; Ikawa M; Sugimoto I; Sakurai Y; Matsuo H; Ando Y; Shimohata T; Nakane S
J Neuroimmunol; 2020 Dec; 349():577399. PubMed ID: 32980672
[TBL] [Abstract][Full Text] [Related]
26. Psychiatric manifestations of autoimmune encephalitis.
Ford H; Griffith S; Warren N; Swayne A; Blum S; Butzkueven H; O'Brien TJ; Velakoulis D; Kulkarni J; Monif M
Autoimmun Rev; 2022 Sep; 21(9):103145. PubMed ID: 35840036
[TBL] [Abstract][Full Text] [Related]
27. [An Update on Therapeutic Management in Autoimmune Encephalitis].
Kamei S
Brain Nerve; 2023 May; 75(5):479-484. PubMed ID: 37194516
[TBL] [Abstract][Full Text] [Related]
28. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.
Kaneko J; Kanazawa N; Tominaga N; Kaneko A; Suga H; Usui R; Ishima D; Kitamura E; Akutsu T; Yoshida K; Nishiyama K; Iizuka T
J Neurol Sci; 2018 Jul; 390():26-32. PubMed ID: 29801900
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology and Clinical Management of Autoimmune Encephalitis-Associated Seizures.
Zhu S; Yu J; Wu Y; Peng J; Xie X; Zhang X; Xie H; Sui L
Neuroimmunomodulation; 2022; 29(4):282-295. PubMed ID: 35580556
[TBL] [Abstract][Full Text] [Related]
30. Therapy response in seronegative versus seropositive autoimmune encephalitis.
Berger B; Hauck S; Runge K; Tebartz van Elst L; Rauer S; Endres D
Front Immunol; 2023; 14():1196110. PubMed ID: 37325671
[TBL] [Abstract][Full Text] [Related]
31. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
[TBL] [Abstract][Full Text] [Related]
32. [Autoimmune encephalitis-An update].
Heine J; Duchow A; Rust R; Paul F; Prüß H; Finke C
Nervenarzt; 2023 Jun; 94(6):525-537. PubMed ID: 36515716
[TBL] [Abstract][Full Text] [Related]
33. Validation of different predictive scoring scales in patients with new-onset epileptic seizures or epilepsy related to neuronal surface antibody-mediated autoimmune encephalitis.
Duan Y; Zhang Z; Zhao X; Cheng H; Zhang S; Guo S; Jin B; Wu X; Aung T
Epilepsy Behav; 2023 Oct; 147():109403. PubMed ID: 37660404
[TBL] [Abstract][Full Text] [Related]
34. Acute symptomatic seizures, epilepsy, and autoimmune encephalitis: Clarifying terminology in neural antibody-associated disease.
Budhram A; Burneo JG
Epilepsia; 2023 Feb; 64(2):306-310. PubMed ID: 36471647
[No Abstract] [Full Text] [Related]
35. Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort.
Douma B; Ben Younes T; Benrhouma H; Miladi Z; Zamali I; Rouissi A; Klaa H; Kraoua I; Ben Ahmed M; Ben Youssef Turki I
J Immunol Res; 2021; 2021():6666117. PubMed ID: 34056010
[TBL] [Abstract][Full Text] [Related]
36. [Autoimmune encephalitis : an update].
Mattar A; Honnorat J; Joubert B
Rev Prat; 2022 Jan; 72(1):85-90. PubMed ID: 35258262
[TBL] [Abstract][Full Text] [Related]
37. [Clinical validation of the 2020 diagnostic approach for pediatric autoimmune encephalitis in a single center].
Wang JD; Xie L; Fang X; Zhuo ZH; Jin PN; Fan XL; Li HY; Kong HM; Wang Y; Wang HL
Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):786-791. PubMed ID: 35922189
[No Abstract] [Full Text] [Related]
38. Neuropsychiatric Manifestations of Autoimmune Encephalitis in a Tertiary Hospital: A Case Series and Current Perspectives.
Sinha A; Smolik TJ; Roy K; Bollu PC
J Clin Psychiatry; 2022 Feb; 83(2):. PubMed ID: 35172047
[No Abstract] [Full Text] [Related]
39. A critical review and update on autoimmune encephalitis: understanding the alphabet soup.
Simabukuro MM; Silva GDD; Castro LHM; Lucato LT
Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):143-158. PubMed ID: 35976312
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
Nissen MS; Ryding M; Meyer M; Blaabjerg M
CNS Neurol Disord Drug Targets; 2020; 19(8):584-598. PubMed ID: 32640967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
